Skin whitening composition containing chia seed extract
WIPO Patent Application WO/2011/109139
Publication Date: Sept. 9, 2011
Assignee: Access Business Group International LLC, J Rana, G Diwakar and J Scholten
The disclosed topical composition includes an alcohol-extracted Salvia hispanica seed extract in a glycol carrier in an amount effective for inhibiting melanin content in an individual. The extract may be extracted in a C1-C4 ethanol and resuspended in a glycol carrier with one or more permeation enhancers. The topical composition may further include a Punica granatum extract. Methods for making and using the composition for whitening skin in an individual are also described.
Skin-whitening agent, anti-aging agent and skin care cosmetic agent
United States Patent Application 20110212041
Publication Date: Sept. 1, 2011
Inventors: K Tohi and H Iwahashi
A skin-whitening agent or anti-aging agent is provided that contains at least one of the following extracts: bayberry extract, blue flag extract, Japanese pepper extract, cowslip extract, lemon verbena extract, hairy agrimony extract, blueberry extract, celery extract, salt cedar extract and passion fruit extract.
The skin-whitening agent has at least one activity selected from the group consisting of: tyrosinase inhibitory activity, activity to suppress melanin production, activity to suppress the expression of SCF mRNA, activity to suppress the expression of endothelin-1 mRNA, activity to suppress the expression of bFGF mRNA and activity to suppress the expression of POMC mRNA.
Herbal composition for maintaining/caring the skin around the eye, methods of preparing the same and uses thereof
US Patent 8007837
Publication Date: Aug. 30, 2011
Assignee: Himalaya Global Holdings Ltd.
Disclosed is a herbal composition for maintaining/caring the skin around the eye, the composition comprising extracts of Saxifraga ligulata syn. Bergenia ligulata, Cipadessa baccifera and Emblica officinalis and cosmeceutical excipients thereof. Also disclosed is a method of extraction, delivery system comprising the same and use thereof.
Method for treating skin with booster compositions
US Patent Application 20110206626
Publication Date: Aug. 25, 2011
Assignee: Conopco Inc. and D/B/A Unilever
A skin care product comprising from about 0.001% to about 10% of a retinoid, in combination with 0.0001% to about 50% of a combination of retinoid boosters is diclosed. Also included is a method for treating skin for wrinkles, psoriasis, age spots and/or discoloration by applying to the skin a composition comprising: from 0.01% to 10% of a retinoid; at least one booster compound selected from the group consisting of farnesol, glycyrrhetinic acid and ursolic acid; and a cosmetically acceptable vehicle.
Cosmetic composition comprising at least one active agent and particles containing at least one colored inorganic pigment in a matrix, and skin care use thereof
US Patent Application 20110206748
Publication Date: Aug. 25, 2011
Assignee: L'Oreal S.A
Disclosed herein is a cosmetic composition for treating and/or caring for the skin, which comprises, in a physiologically acceptable medium, at least one cosmetic active agent and at least one colored particle comprising at least one inorganic pigment arranged inside a matrix, wherein the composition has an opacity of less than or equal to 35%. Also disclosed herein is a cosmetic treatment process comprising applying this composition to keratin materials. Further disclosed herein is a method for lightening and/or unifying the complexion of the skin and/or for correcting the appearance of skin marks and dyschromias comprising applying a composition of the present disclosure to the skin.
Compositions and methods for modulating skin pigmentation
US Patent Application 20110206625
Publication Date: Aug. 25, 2011
Assignee: SM Singh and DJ Tobin
The present invention relates to compositions and methods useful in studying or modulating melanin pigmentation in the skin. Particularly, the invention relates to compositions comprising a substance capable of modulating the activity or expression of ALK6 (SEQ ID 2) or Cdc42 which in turn are capable of modulation of the transfer of melanin from melanocytes to keratinocytes and potentially from keratinocytes to keratinocytes. The invention also relates to assays for identifying such compositions, and methods of modulating skin pigmentation.
Cosmetic composition for lightening or unifying the complexion
European Patent Application EP23599
Publication Date: Aug. 24, 2011
The present invention relates to a composition comprising, in a physiologically acceptable medium, concave or annular particles, especially in the form of hollow sphere portions, the said particles comprising a matrix that is colored in the bulk. The present invention relates to a composition for topical application, intended, especially in the case of skin displaying dyschromia of the type caused by pigmentation marks, red blotches or shadows under the eyes, for lightening or unifying the complexion.
The composition according to the invention may especially be a skin care product or a makeup product, especially a foundation. It is commonplace for people with colored skin, or with pigmentation marks, red blotches or shadows under the eyes, to wish to correct these types of cutaneous dyschromia, and for this purpose use cosmetic or dermatological compositions that allow the complexion to be lightened and unified. To this end, it is known practice to use cosmetic compositions containing bleaching agents. However, it is necessary, to use these agents for a prolonged period and in large amounts in order to observe a bleaching effect on the skin. Furthermore, an effect is not observed immediately on application of the compositions comprising them. For the purpose of immediate lightening and unifying of the complexion, it is also known practice to use cosmetic compositions containing fluorescent compounds, with a particular focus on optical brighteners.
A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation
WIPO Patent Application WO/2011/098391
Publication Date: Aug. 18, 2011
Assignee: Galderma Research & Development, J-C Dhun, N Kerrouche and P Soto
A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- Caucasian population with decrease of post- inflammatory hyperpigmentation, keloid scarring and acne hyperpigmented macules and cystic lesions. Acne vulgaris, also known as polymorphic acne is most common. It includes four stages, but passage through all stages is not obligatory: Stage 1 corresponds to acne with comedones characterized by a large number of open comedones and/or closed, and microcysts; stage 2 or papulopustular acne is mild to moderate, characterized by the presence of open comedones and/or closed, microcysts, but also red papules and pustules and mainly affects the face and leaves little scarring; and stage 3 or papulocomedonienne acne is more severe and extends to the back, chest and shoulders and is accompanied by a greater number of scars.
Compositions and methods for reducing appearance of under-eye dark circles
WIPO Patent Application WO/2011/097617
Publication Date: Aug. 11, 2011
Assignee: ELC Management LLC and DB YAROSH
A cosmetic or dermatological composition is provided for reducing appearance of under-eye dark circles that contains at least one bicyclic monoterpene diol and at least one skin lightening agent in a cosmetically or pharmaceutically acceptable carrier. The composition may further contain at least one anti-angiogenic agent and/or at least one anti-inflammatory agent.
Compounds, compositions and methods for preventing skin darkening
WIPO Patent Application WO/2011/094016
Publication Date: Aug. 4, 2011
Assignee: New York University, J Seth and LN Komatsu
A method for preventing hyperpigmented skin, undesired pigmentation disorder of skin, or undesired darkening of skin using coumarin compounds, the use of such compounds, and compositions and formulations thereof are disclosed. In a particular embodiment, the coumarin compounds are selected from robustic acid methyl ether, scandenin, and coumophos. The compounds may be prepared as additives to pharmaceutical and cosmetic compositions, and in personal care products such as antiperspirants. In a particular embodiment extends to an antiperspirant product containing a skin darkening inhibitory amount of a compound of the invention. Also, the present skin darkening compounds may be prepared in combination with each other. The compounds, compositions and formulations of the invention may be used for the prevention of the onset or progression of conditions characterized by unwanted skin darkening, including those that may be causally related to aberrant melanogenesis activity including, by way of non-limiting example, hyperpigmentation and others.